Tuttle Capital Management’s Alpha Tau Medical DRTS Stock Holding History

Tuttle Capital Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,221	Closed	-$2.38K	–	54
2024 Q3	$2.38K	Hold	12,221	–	–	0.01%	57
2024 Q2	$2.93K	Hold	12,221	–	–	0.02%	51
2024 Q1	$3.06K	Hold	12,221	–	–	0.02%	43
2023 Q4	$2.35K	Hold	12,221	–	–	0.02%	46
2023 Q3	$3.25K	Hold	12,221	–	–	0.02%	50
2023 Q2	$4.83K	Buy	+12,221	New	+$43.8K	0.02%	51
2022 Q4	–	Sell	-10,778	Closed	-$5K	–	97
2022 Q3	$5K	Buy	+10,778	New	+$95.1K	0.02%	84

Other funds holding DRTS

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAM

Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Tuttle Capital Management's DRTS Position: Q4 2024 in Review

Tuttle Capital Management sold out of Alpha Tau Medical (DRTS) in Q4 2024, closing a stake of 12,221 shares — an estimated $2.38K sold.

Tuttle Capital Management first reported a position in DRTS in Q3 2022 and held it in 7 quarters. The position peaked at $5K in Q3 2022. 21 funds tracked by Wall St. Rank hold DRTS as of Q4 2024.

Tuttle Capital Management reported no remaining Alpha Tau Medical position as of Q4 2024 after selling out during the quarter.
Tuttle Capital Management sold 12,221 Alpha Tau Medical shares in Q4 2024, an estimated $2.38K.
Tuttle Capital Management first reported a position in Alpha Tau Medical in Q3 2022 and held it in 7 quarters.
Tuttle Capital Management's Alpha Tau Medical position peaked at $5K in Q3 2022.
21 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2024.

Based on Tuttle Capital Management's 13F filing for Q4 2024, filed 14 Jan 2025.